Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARA290 effects on emotional processing in healthy volunteers
2010-024364-18Phase 2Active
- Sponsor
- Leiden University
- Start
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of cibinetide in major depressive disorder (MDD), sponsored by Leiden University. Primary endpoint: Accuracy and speed to recognize facial expressions of emotions. Started Jan 2011; status: active.
02
Drugs
cibinetide
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2010-024364-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024364-18.